1. Home
  2. BPMC vs CADE Comparison

BPMC vs CADE Comparison

Compare BPMC & CADE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BPMC
  • CADE
  • Stock Information
  • Founded
  • BPMC 2008
  • CADE 1876
  • Country
  • BPMC United States
  • CADE United States
  • Employees
  • BPMC N/A
  • CADE N/A
  • Industry
  • BPMC Biotechnology: Pharmaceutical Preparations
  • CADE Major Banks
  • Sector
  • BPMC Health Care
  • CADE Finance
  • Exchange
  • BPMC Nasdaq
  • CADE Nasdaq
  • Market Cap
  • BPMC 5.8B
  • CADE 6.4B
  • IPO Year
  • BPMC 2015
  • CADE N/A
  • Fundamental
  • Price
  • BPMC $84.69
  • CADE $27.91
  • Analyst Decision
  • BPMC Buy
  • CADE Buy
  • Analyst Count
  • BPMC 22
  • CADE 12
  • Target Price
  • BPMC $124.48
  • CADE $38.17
  • AVG Volume (30 Days)
  • BPMC 1.2M
  • CADE 1.5M
  • Earning Date
  • BPMC 05-01-2025
  • CADE 04-21-2025
  • Dividend Yield
  • BPMC N/A
  • CADE 3.95%
  • EPS Growth
  • BPMC N/A
  • CADE N/A
  • EPS
  • BPMC N/A
  • CADE 2.77
  • Revenue
  • BPMC $508,824,000.00
  • CADE $1,721,725,000.00
  • Revenue This Year
  • BPMC $45.70
  • CADE $12.15
  • Revenue Next Year
  • BPMC $31.83
  • CADE $7.04
  • P/E Ratio
  • BPMC N/A
  • CADE $10.08
  • Revenue Growth
  • BPMC 104.04
  • CADE 49.06
  • 52 Week Low
  • BPMC $73.04
  • CADE $25.22
  • 52 Week High
  • BPMC $121.90
  • CADE $40.20
  • Technical
  • Relative Strength Index (RSI)
  • BPMC 47.15
  • CADE 42.17
  • Support Level
  • BPMC $78.66
  • CADE $27.47
  • Resistance Level
  • BPMC $83.50
  • CADE $29.09
  • Average True Range (ATR)
  • BPMC 5.00
  • CADE 1.46
  • MACD
  • BPMC 0.20
  • CADE 0.08
  • Stochastic Oscillator
  • BPMC 67.15
  • CADE 50.19

About BPMC Blueprint Medicines Corporation

Blueprint Medicines Corp is a biopharmaceutical company. It is focused on improving the lives of patients with diseases driven by abnormal kinase activation. The company has developed a small molecule drug pipeline in cancer and a rare genetic disease. Its drug candidates includes AYVAKIT for the treatment of systemic mastocytosis, BLU-808 a potential treatment for mast cell disorders, including chronic urticaria, sleep disruption and other related diseases. It also has other drugs in its pipeline such as BLU-956, BLU-222 for treatment of breast cancer.

About CADE Cadence Bank

Cadence Bank is a bank based in the United States. The operating segments are Corporate Banking segment focuses on C&I, business banking, and commercial real estate lending to clients in the geographic footprint, Community Banking segment provides a broad range of banking services through the branch network to serve the needs of community businesses and individual consumers in the geographic footprint, Mortgage segment includes mortgage banking activities of originating mortgage loans, selling mortgage loans in the secondary market and servicing the mortgage loans, Banking Services segment offers individuals, businesses, governmental institutions, and non-profit entities a widerange of solutions to help protect, grow, and transfer wealth, General Corporate and Other segment.

Share on Social Networks: